Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|88|6|377-384

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.6, 2015-0, pp. : 377-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapy in HER2-Positive Breast Cancer

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 295-302

Karger

Access to resources Recommend Favorite

Neoadjuvant Therapy for HER2-positive Breast Cancer

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 81-92

Bentham Science Publishers

Access to resources Recommend Favorite

Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer

By Boyraz Baris Sendur Mehmet A.N. Aksoy Sercan Babacan Taner Roach Emir C. Kizilarslanoglu Muhammet C. Petekkaya Ibrahim Altundag Kadri

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 405-414

Informa Healthcare

Access to resources Recommend Favorite

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer

By Haq Bushra Geyer Charles E

Women's Health, Vol. 5, Iss. 2, 2009-03 ,pp. : 135-147

Future Medicine

Access to resources Recommend Favorite

Trastuzumab as Single Agent Therapy for HER2-Positive Metastatic Breast Cancer

Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. : 420-421

Karger

Access to resources Recommend Favorite